122 related articles for article (PubMed ID: 33906292)
1. RET Protein Expression in Colorectal Cancer; An Immunohistochemical Assessment.
Ashkboos M; Nikbakht M; Zarinfard G; Soleimani M
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1019-1023. PubMed ID: 33906292
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Immuno-Histochemical Expression of MBD1 in Colorectal Adenocarcinoma and Its Correlations with Prognostic Factors.
Ghaedamini S; Nikbakht M; Soleimani M
Middle East J Dig Dis; 2020 Jan; 12(1):39-44. PubMed ID: 32082520
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of RET fusions in advanced colorectal cancer.
Le Rolle AF; Klempner SJ; Garrett CR; Seery T; Sanford EM; Balasubramanian S; Ross JS; Stephens PJ; Miller VA; Ali SM; Chiu VK
Oncotarget; 2015 Oct; 6(30):28929-37. PubMed ID: 26078337
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Correlation Between MFG-E8 Expression Level and Colorectal Cancer.
Jia M; Yao H; Chen C; Wang Y; Wang H; Cui T; Zhu J
Arch Med Res; 2017 Apr; 48(3):270-275. PubMed ID: 28923329
[TBL] [Abstract][Full Text] [Related]
5. Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients.
Draht MX; Smits KM; Tournier B; Jooste V; Chapusot C; Carvalho B; Cleven AH; Derks S; Wouters KA; Belt EJ; Stockmann HB; Bril H; Weijenberg MP; van den Brandt PA; de Bruïne AP; Herman JG; Meijer GA; Piard F; Melotte V; van Engeland M
Mol Oncol; 2014 May; 8(3):679-88. PubMed ID: 24560444
[TBL] [Abstract][Full Text] [Related]
6. Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis.
Shi H; Zhou Y; Liu H; Chen C; Li S; Li N; Li X; Zhang X; Zhang H; Wang W; Zhao Q
BMC Cancer; 2010 Sep; 10():477. PubMed ID: 20815902
[TBL] [Abstract][Full Text] [Related]
7. Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.
Gao JY; Song BR; Peng JJ; Lu YM
World J Gastroenterol; 2012 Nov; 18(41):5965-71. PubMed ID: 23139614
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
9. RET is a potential tumor suppressor gene in colorectal cancer.
Luo Y; Tsuchiya KD; Il Park D; Fausel R; Kanngurn S; Welcsh P; Dzieciatkowski S; Wang J; Grady WM
Oncogene; 2013 Apr; 32(16):2037-47. PubMed ID: 22751117
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer.
Zeng J; Tang ZH; Liu S; Guo SS
World J Gastroenterol; 2017 Mar; 23(10):1780-1786. PubMed ID: 28348483
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of p63 cytoplasmic expression in colorectal cancer. An immunohistochemical study.
Albasri AM; Elkablawy MA; Ansari IA; Alhujaily AS; Khalil AA
Saudi Med J; 2019 May; 40(5):432-439. PubMed ID: 31056618
[TBL] [Abstract][Full Text] [Related]
12. Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification.
Mian C; Pennelli G; Barollo S; Cavedon E; Nacamulli D; Vianello F; Negro I; Pozza G; Boschin IM; Pelizzo MR; Rugge M; Mantero F; Girelli ME; Opocher G
Eur J Endocrinol; 2011 Jun; 164(6):971-6. PubMed ID: 21422198
[TBL] [Abstract][Full Text] [Related]
13. [Association of Bmi-1 expression with clinicopathological features and prognosis of colorectal cancer].
Lin MX; Wen ZF; Feng ZY; Li ZK
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Sep; 29(9):1816-9. PubMed ID: 19778799
[TBL] [Abstract][Full Text] [Related]
14. High expression of P2X7R is an independent postoperative indicator of poor prognosis in colorectal cancer.
Qian F; Xiao J; Hu B; Sun N; Yin W; Zhu J
Hum Pathol; 2017 Jun; 64():61-68. PubMed ID: 28412208
[TBL] [Abstract][Full Text] [Related]
15. In depth evaluation of the prognostic and predictive utility of PTEN immunohistochemistry in colorectal carcinomas: performance of three antibodies with emphasis on intracellular and intratumoral heterogeneity.
Ágoston EI; Micsik T; Ács B; Fekete K; Hahn O; Baranyai Z; Dede K; Bodoky G; Bursics A; Kulka J; Krenács T; Győrffy B; Harsányi L; Szász AM
Diagn Pathol; 2016 Jul; 11(1):61. PubMed ID: 27392434
[TBL] [Abstract][Full Text] [Related]
16. Low expression of adenomatous polyposis coli 2 correlates with aggressive features and poor prognosis in colorectal cancer.
Sun Y; Tian H; Xu X; Wang L
Bioengineered; 2020 Dec; 11(1):1027-1033. PubMed ID: 32951505
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-17 is a favorable prognostic marker for colorectal cancer.
Lin Y; Xu J; Su H; Zhong W; Yuan Y; Yu Z; Fang Y; Zhou H; Li C; Huang K
Clin Transl Oncol; 2015 Jan; 17(1):50-6. PubMed ID: 25015721
[TBL] [Abstract][Full Text] [Related]
19. RET fusions in a small subset of advanced colorectal cancers at risk of being neglected.
Pietrantonio F; Di Nicolantonio F; Schrock AB; Lee J; Morano F; Fucà G; Nikolinakos P; Drilon A; Hechtman JF; Christiansen J; Gowen K; Frampton GM; Gasparini P; Rossini D; Gigliotti C; Kim ST; Prisciandaro M; Hodgson J; Zaniboni A; Chiu VK; Milione M; Patel R; Miller V; Bardelli A; Novara L; Wang L; Pupa SM; Sozzi G; Ross J; Di Bartolomeo M; Bertotti A; Ali S; Trusolino L; Falcone A; de Braud F; Cremolini C
Ann Oncol; 2018 Jun; 29(6):1394-1401. PubMed ID: 29538669
[TBL] [Abstract][Full Text] [Related]
20. Expression of Aldehyde Dehydrogenase 1A1 (ALDH1A1) as a Prognostic Biomarker in Colorectal Cancer Using Immunohistochemistry.
Yang W; Wang Y; Wang W; Chen Z; Bai G
Med Sci Monit; 2018 May; 24():2864-2872. PubMed ID: 29748529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]